Medication-associated osteonecrosis of the jaw

Oct 31, 2018

Study: Denosumab Effective in Treating Osteoporosis in Transfusion-Dependent Thalassemia

Oct 09, 2018

Are You at Risk for Developing Bone Disease?

Aug 20, 2018

Q BioMed Inc. Announces FDA Filing for Strontium Chloride Sr89 Injection USP for Relief of Metastatic Cancer Bone Pain

Jun 13, 2018

Cerapedics Receives 2018 MedTech Breakthrough Award for Best New Surgical Technology Solution

Jun 08, 2018

European Commission Approves Prolia® (denosumab) for Patients With Glucocorticoid-Induced Osteoporosis

Jun 05, 2018

Patients with diabetes may be at an increased risk of complications after shoulder replacement surgery

May 21, 2018

FDA Approves Prolia® (Denosumab) For Glucocorticoid-Induced Osteoporosis

May 14, 2018

Pfenex Announces Positive Top-Line PF708 Study Results in Osteoporosis Patients, On-Track for Submission of New Drug Application in Third Quarter 2018

May 07, 2018

HSS Researchers Launch Study to Measure Bone Effects of New Rheumatologic Agent

Apr 27, 2018

Amgen Receives Positive CHMP Opinion To Expand Use Of Prolia® (denosumab) To Patients With Glucocorticoid-Induced Osteoporosis

Apr 03, 2018

European Commission Approves Expanded Indication For Amgen's XGEVA® (denosumab) For The Prevention Of Skeletal-Related Events In Patients With Multiple Myeloma

Feb 23, 2018

Amgen Receives Positive Opinion Expanding Use Of XGEVA® (denosumab) To Cover Prevention Of Skeletal-Related Events In Patients With Multiple Myeloma In Europe